EP-027367

N/A

Report date: 2023/01/08 14:04:03
NME

Base Information

Drug NameEP-027367
Drug Alias NameEP-027367
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionViral core proteins inhibitors
TargetsViral core proteins
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnanta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A